614 related articles for article (PubMed ID: 27312194)
1. Fecal calprotectin and C-reactive protein are associated with positive findings in capsule endoscopy in suspected small bowel Crohn's disease.
Egea Valenzuela J; Pereñíguez López A; Pérez Fernández V; Alberca de Las Parras F; Carballo Álvarez F
Rev Esp Enferm Dig; 2016 Jul; 108(7):394-400. PubMed ID: 27312194
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of fecal calprotectin and lactoferrin as predictors of small bowel Crohn's disease in patients undergoing capsule endoscopy.
Bar-Gil Shitrit A; Koslowsky B; Livovsky DM; Shitrit D; Paz K; Adar T; Adler SN; Goldin E
Scand J Gastroenterol; 2017 Mar; 52(3):328-333. PubMed ID: 27841040
[TBL] [Abstract][Full Text] [Related]
3. Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse.
Aggarwal V; Day AS; Connor S; Leach ST; Brown G; Singh R; Friedman A; Zekry A; Craig PI
Gastrointest Endosc; 2017 Dec; 86(6):1070-1078. PubMed ID: 28947363
[TBL] [Abstract][Full Text] [Related]
4. Capsule endoscopic findings correlate with fecal calprotectin and C-reactive protein in patients with suspected small-bowel Crohn's disease.
Höög CM; Bark LÅ; Broström O; Sjöqvist U
Scand J Gastroenterol; 2014 Sep; 49(9):1084-90. PubMed ID: 24853318
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic accuracy of faecal calprotectin and small bowel capsule endoscopy and their correlation in suspected isolated small bowel Crohn's disease.
Hale MF; Drew K; McAlindon ME; Sidhu R
Eur J Gastroenterol Hepatol; 2016 Oct; 28(10):1145-50. PubMed ID: 27384306
[TBL] [Abstract][Full Text] [Related]
6. Fecal calprotectin as a biomarker of inflammatory lesions of the small bowel seen by videocapsule endoscopy.
Egea-Valenzuela J; Alberca-de-Las-Parras F; Carballo-Álvarez F
Rev Esp Enferm Dig; 2015 Apr; 107(4):211-4. PubMed ID: 25824919
[TBL] [Abstract][Full Text] [Related]
7. Fecal calprotectin: a selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy.
Koulaouzidis A; Douglas S; Rogers MA; Arnott ID; Plevris JN
Scand J Gastroenterol; 2011 May; 46(5):561-6. PubMed ID: 21269246
[TBL] [Abstract][Full Text] [Related]
8. Fecal calprotectin for the prediction of small-bowel Crohn's disease by capsule endoscopy: a systematic review and meta-analysis.
Kopylov U; Yung DE; Engel T; Avni T; Battat R; Ben-Horin S; Plevris JN; Eliakim R; Koulaouzidis A
Eur J Gastroenterol Hepatol; 2016 Oct; 28(10):1137-44. PubMed ID: 27415156
[TBL] [Abstract][Full Text] [Related]
9. Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy.
Sipponen T; Haapamäki J; Savilahti E; Alfthan H; Hämäläinen E; Rautiainen H; Koskenpato J; Nuutinen H; Färkkilä M
Scand J Gastroenterol; 2012 Jul; 47(7):778-84. PubMed ID: 22519419
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic and predictive value of fecal calprotectin and capsule endoscopy for small-bowel Crohn's disease: a systematic review and meta-analysis.
Xiang B; Dong Z; Dai C
Rev Esp Enferm Dig; 2021 Mar; 113(3):193-201. PubMed ID: 33207888
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a scoring index to predict the presence of lesions in capsule endoscopy in patients with suspected Crohn's disease of the small bowel: a Spanish multicenter study.
Egea-Valenzuela J; González Suárez B; Sierra Bernal C; Juanmartiñena Fernández JF; Luján-Sanchís M; San Juan Acosta M; Martínez Andrés B; Pons Beltrán V; Sastre Lozano V; Carretero Ribón C; de Vera Almenar F; Sánchez Cuenca J; Alberca de Las Parras F; Rodríguez de Miguel C; Valle Muñoz J; Férnandez-Urién Sainz I; Torres González C; Borque Barrera P; Pérez-Cuadrado Robles E; Alonso Lázaro N; Martínez García P; Prieto de Frías C; Carballo Álvarez F
Eur J Gastroenterol Hepatol; 2018 May; 30(5):499-505. PubMed ID: 29489472
[TBL] [Abstract][Full Text] [Related]
12. Elevated Faecal Calprotectin Levels are a Reliable Non-Invasive Screening Tool for Small Bowel Crohn's Disease in Patients Undergoing Capsule Endoscopy.
Yousuf H; Aleem U; Egan R; Maheshwari P; Mohamad J; McNamara D
Dig Dis; 2018; 36(3):202-208. PubMed ID: 29466790
[TBL] [Abstract][Full Text] [Related]
13. [The Capsule Endoscopy Crohn's Disease Activity Index, clinical activity and fecal calprotectin level in patients with isolated small intestine lesions].
Timerbulatov MV; Grishina EE; Aitova LR; Senderovich EI; Ziganshin TM
Khirurgiia (Mosk); 2021; (9):63-70. PubMed ID: 34480457
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease.
Jusué V; Chaparro M; Gisbert JP
Dig Liver Dis; 2018 Apr; 50(4):353-359. PubMed ID: 29396129
[TBL] [Abstract][Full Text] [Related]
15. The combination of fecal calprotectin with ESR, CRP and albumin discriminates more accurately children with Crohn's disease.
Daniluk U; Daniluk J; Krasnodebska M; Lotowska JM; Sobaniec-Lotowska ME; Lebensztejn DM
Adv Med Sci; 2019 Mar; 64(1):9-14. PubMed ID: 30237086
[TBL] [Abstract][Full Text] [Related]
16. Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon.
Jensen MD; Kjeldsen J; Nathan T
Scand J Gastroenterol; 2011 Jun; 46(6):694-700. PubMed ID: 21456899
[TBL] [Abstract][Full Text] [Related]
17. Utility of video capsule endoscopy for longitudinal monitoring of Crohn's disease activity in the small bowel: a prospective study.
Melmed GY; Dubinsky MC; Rubin DT; Fleisher M; Pasha SF; Sakuraba A; Tiongco F; Shafran I; Fernandez-Urien I; Rosa B; Papageorgiou NP; Leighton JA
Gastrointest Endosc; 2018 Dec; 88(6):947-955.e2. PubMed ID: 30086261
[TBL] [Abstract][Full Text] [Related]
18. Fecal Calprotectin as a Selection Tool for Small Bowel Capsule Endoscopy in Suspected Crohn's Disease.
Monteiro S; Barbosa M; Cúrdia Gonçalves T; Boal Carvalho P; Moreira MJ; Rosa B; Cotter J
Inflamm Bowel Dis; 2018 Aug; 24(9):2033-2038. PubMed ID: 29722829
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of the assessment of fecal calprotectin in Leśniowski-Crohn's disease.
Eder P; Stawczyk-Eder K; Krela-Kaźmierczak I; Linke K
Pol Arch Med Wewn; 2008 Nov; 118(11):622-6. PubMed ID: 19140565
[TBL] [Abstract][Full Text] [Related]
20. Prediction of disease activity of Crohn's disease through fecal calprotectin evaluated by balloon-assisted endoscopy.
Iwamoto F; Matsuoka K; Motobayashi M; Takenaka K; Kuno T; Tanaka K; Tsukui Y; Kobayashi S; Yoshida T; Fujii T; Saito E; Yamaguchi T; Nagahori M; Sato T; Ohtsuka K; Enomoto N; Watanabe M
J Gastroenterol Hepatol; 2018 Dec; 33(12):1984-1989. PubMed ID: 29889986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]